Minomic International has signed an agreement with Minomic Pty Ltd to commercialise biomarkers for the diagnosis and treatment of major diseases.
The first release is a diagnostic for Prostate Cancer, a disease that is found in men. With over 60 million men expected to have a Prostate Cancer screening test in 2008, the diagnostic is timely and provides a more accurate and non-invasive form of diagnosis.
For more information on updated announcements, please contact info@minomic.com |
